D-Dimer Level Among COVID-19 Patients as Biological Mediator for Hyper Coagulation State

Shahd Adil Mohammed Omer, Elharam Ibrahim Abdallah, Abdel Rahim Mahmoud Muddathir, Alaa Eltayeb Omer, Lienda Bashier Eltayeb

Research output: Contribution to journalArticlepeer-review

Abstract

Background and Objective: Viremia due to SARS-CoV-2 lead variety of biochemical change in the human body, which play a crucial role in the activation of the coagulation cascade causing thrombotic complications and coagulopathies. The study aimed to ascertain the D-dimer level as a biological mediator in COVID-19 patients in Khartoum state and compare the results to the control group. Materials and Methods: A cross-sectional study was conducted during the period of August to December, 2021, including 50 healthy patients and 50 COVID-19 patients, blood samples were collected from study groups for measurement of D-dimer level using an I Chroma device. Statistical analysis was conducted using SSPS version 21. Results: This study revealed a statistically increased D-dimer level among COVID-19 patients compared with the control group (2000-10000 vs. up to 500 ng mLG1), respectively. Conclusion: Viremia induced by COVID-19 infection can cause a high D-dimer level which can lead to thrombosis event or bleeding tendency.

Original languageEnglish
Pages (from-to)569-574
Number of pages6
JournalPakistan Journal of Biological Sciences
Volume25
Issue number6
DOIs
StatePublished - 2022

Keywords

  • coagulation cascade
  • D-dimer
  • hyper coagulopathy
  • SARS-CoV-2
  • thromboembolism
  • thrombosis
  • viremia

Fingerprint

Dive into the research topics of 'D-Dimer Level Among COVID-19 Patients as Biological Mediator for Hyper Coagulation State'. Together they form a unique fingerprint.

Cite this